Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression
- 319 Downloads
The blood-brain barrier (BBB) is a structural and functional barrier between the interstitial fluid of the brain and the blood; the barrier maintains the precisely controlled biochemical environment that is necessary for neural function. This constellation of endothelial cells, macrophages, pericytes, and astrocytes forms the neurovascular unit which is the structural and functional unit of the blood-brain barrier. Peptides enter and exit the CNS by transport systems expressed by the capillary endothelial cells of the neurovascular unit. Limiting the transport of peptides and proteins into the brain are efflux transporters like P-gp are transmembrane proteins present on the luminal side of the cerebral capillary endothelium and their function is to promote transit and excretion of drugs from the brain to the blood. Nanocarrier systems have been developed to exploit transport systems for enhanced BBB transport. Recent approaches for enhancing endogenous peptide expression are discussed.
KeywordsNeuropeptides Oxytocin Blood-brain barrier (BBB) Receptor mediated transcytosis (RMT) CRISPR/Cas9-gRNA
This work was supported by the Bench-to-Bedside (B2B) Grant (PI: Lee) and grant #R03DA044887-02 (PI- Jayant) funded by the National Institutes of Health (NIH).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Althammer F, Grinevich V (2017) Diversity of oxytocin neurons: behyond mango- and parvocellular cell types? J Neuroendocrinol. https://doi.org/10.1111/jne.12549
- Banks WA, Kastin AJ, Komaki G, Arimura A (1993) Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267:690–696Google Scholar
- Blanchette M, Fortin D (2011) Blood-brain barrier disruption in the treatment of brain tumors. The Blood-Brain and Other Neural Barriers Springer, pp 447–463Google Scholar
- Dufes C (2011) Brain delivery of peptides and proteins. In Peptide and Protein Delivery. Elsevier, pp 105–122. https://doi.org/10.1016/B978-0-12-384935-9.10006-9
- Engert V, Koester AM, Riepenhausen A, Singer T (2016) Boosting recovery rather than buffering reactivity: higher stress-induced oxytocin secretion is associated with increased cortisol reactivity and faster vagal recovery after acute psychosocial stress. Psychoneuroendocrinology 74:111–120CrossRefGoogle Scholar
- Gainer H (1998) Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons. In: Zingg HH, Bourque CW, Bichet DG (eds) Vasopressin and Oxytocin. Springer, Boston, pp 15–27Google Scholar
- Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ (2000) Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294:73–79Google Scholar
- Milligan KA, Winstead C, Smith J (2018) Preparation and physiochemical characterization of chitosan nanoparticles for controlled delivery of oxytocin. Int J Pharm Sci Res 9:1430–1440Google Scholar
- Oldendorf WH (1971) Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Phys 221:1629–1639Google Scholar
- Rout AK, Singh H, Patel S, Raghvaan V, Gautam S, Minda R, Rao BJ, Chary KVR (2018) Structural Characterization of a novel KH-domain containing plant chloroplast endonuclease. Scientific reports 8:13750Google Scholar
- Uhrig S, Hirth N, Broccoli L, von Wilmsdorff M, Bauer M, Sommer C, Zink M, Steiner J, Frodl T, Malchow B, Falkai P, Spanagel R, Hansson AC, Schmitt A (2016) Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: a post-mortem study. Schizophr Res 177:59–66CrossRefGoogle Scholar